HIV and malaria interactions: where do we stand?

被引:0
|
作者
Gonzalez, Raquel [1 ]
Ataide, Ricardo [2 ]
Naniche, Denise [1 ]
Menendez, Clara [1 ]
Mayor, Alfredo [1 ]
机构
[1] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona Ctr Int Heath Res CRESIB, E-08007 Barcelona, Spain
[2] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh EH8 9YL, Midlothian, Scotland
关键词
antimalarial; antiretrovirals; drug; epidemiology; HIV; immunity; impact; interaction; malaria; HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMODIUM-FALCIPARUM-MALARIA; TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; PLACENTAL MALARIA; PREGNANT-WOMEN; VIRAL LOAD; COTRIMOXAZOLE PROPHYLAXIS; PROTEASE INHIBITORS; CELL COUNT;
D O I
10.1586/ERI.11.167
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Reversing the spread of HIV infection and the incidence of malaria constitute two of the Millenium Development Goals. However, despite recent achievements, both diseases still entail global heath problems. Furthermore, their overlapping geographical distribution raises concerns and challenges for potential immunological, clinical and therapeutic interactions. It has been reported that HIV infection increases malaria susceptibility and reduces the efficacy of antimalarial drugs. On the other hand, the effect of malaria on HIV-infected individuals has also been explored, with the parasitic infection increasing the risk of HIV disease progression and mother-to-child transmission of HIV. The spread of malaria and parasite resistance to antimalarials could also be accelerated by HIV-associated immunosuppresion. Current knowledge of the epidemiological, clinical, immunological and therapeutic interactions of the two diseases is reviewed in this article. We focus on the latest available data, pointing out key future research areas and challenges of the field.
引用
收藏
页码:153 / 165
页数:13
相关论文
共 50 条
  • [21] HIV and malaria: interactions and implications
    Slutsker, Laurence
    Marston, Barbara J.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2007, 20 (01) : 3 - 10
  • [22] Global Iodine Nutrition: Where Do We Stand in 2013?
    Pearce, Elizabeth N.
    Andersson, Maria
    Zimmermann, Michael B.
    THYROID, 2013, 23 (05) : 523 - 528
  • [23] Anesthesia for carotid endarterectomy: where do we stand at present?
    Unic-Stojanovic, Dragana
    Radak, Djordje
    Gojkovic, Tamara
    Matic, Predrag
    Rankovic, Ljiljana
    Jovic, Miomir
    SIGNA VITAE, 2015, 10 (02)
  • [24] Cardioband®: Where do we stand, who are suitable patients?
    Frerker, C.
    Schmidt, T.
    Pfister, R.
    Koerber, M. I.
    Mauri, V.
    Woesten, M.
    Baldus, S.
    HERZ, 2019, 44 (07) : 596 - 601
  • [25] Infectious endocarditis in the case of cirrhosis: where do we stand?
    Allaire, Manon
    Ollivier-Hourmand, Isabelle
    Garioud, Armand
    Heng, Ratmony
    Thong Dao
    Cadranel, Jean-Francois D.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (12) : 1406 - 1410
  • [26] Bladder Pain Syndrome: Where Do We Stand Now?
    Chang Kit L.
    Current Bladder Dysfunction Reports, 2014, 9 (1) : 32 - 40
  • [27] Alcohol and cardiovascular diseases: where do we stand today?
    Klatsky, A. L.
    JOURNAL OF INTERNAL MEDICINE, 2015, 278 (03) : 238 - 250
  • [28] Lung cancer in Eastern Morocco: where do we stand?
    Belmokhtar, Karam Yahya
    Tajir, Mariam
    Boulouiz, Redouane
    Bennani, Amal
    Brahmi, Sami Aziz
    Alloubi, Ihsan
    Kouismi, Hatim
    Kamaoui, Imane
    Skiker, Imane
    Afqir, Said
    Abda, Naima
    Bellaoui, Mohammed
    Mezouar, Loubna
    PAN AFRICAN MEDICAL JOURNAL, 2019, 34
  • [29] Immunotherapy in Head and Neck Cancer: Where Do We Stand?
    Vallianou, Natalia G.
    Evangelopoulos, Angelos
    Kounatidis, Dimitris
    Panagopoulos, Fotis
    Geladari, Eleni
    Karampela, Irene
    Stratigou, Theodora
    Dalamaga, Maria
    CURRENT ONCOLOGY REPORTS, 2023, 25 (08) : 897 - 912